Speciality Medicines Private Limited — Pembrolizumab Exporter Profile
Indian Pharmaceutical Exporter · #6 for Pembrolizumab · $159.8K export value · DGFT Verified
Speciality Medicines Private Limited is the #6 Indian exporter of Pembrolizumab with $159.8K in export value and 19 verified shipments. Speciality Medicines Private Limited holds a 8.3% market share in Pembrolizumab exports across 3 countries. The company exports 4 pharmaceutical products worth $217.1K across 2 therapeutic categories.
Speciality Medicines Private Limited — Pembrolizumab Export Profile: Buyers & Destinations
Where Does Speciality Medicines Private Limited Export Pembrolizumab?
| Country | Value | Shipments | Share |
|---|---|---|---|
| BRAZIL | $285.4K | 34 | 89.5% |
| ST KITTS-NEVIS-ANGUILLA | $19.7K | 2 | 6.2% |
| LITHUANIA | $13.7K | 3 | 4.3% |
Speciality Medicines Private Limited exports Pembrolizumab to 3 countries. The largest destination is BRAZIL accounting for 89.5% of Speciality Medicines Private Limited's Pembrolizumab shipments, followed by ST KITTS-NEVIS-ANGUILLA (6.2%) and LITHUANIA (4.3%). These destinations reflect Speciality Medicines Private Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Pembrolizumab from Speciality Medicines Private Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| TO THE ORDER | BRAZIL | $222.0K | 27 |
| TO THE ORDER OF | BRAZIL | $55.4K | 7 |
| TO THE ORDER OF. | BRAZIL | $12.9K | 2 |
| BETANIA DALBEM DIAS PETIERA | BRAZIL | $9.5K | 1 |
| PATIENT BETANIA DALBEM DIAS | BRAZIL | $9.5K | 1 |
| PATIENT: BETANIA DALBEM DIAS PEREIR | BRAZIL | $9.5K | 1 |
Speciality Medicines Private Limited supplies Pembrolizumab to 6 buyers globally. The largest buyer is TO THE ORDER (BRAZIL), followed by TO THE ORDER OF (BRAZIL) and TO THE ORDER OF. (BRAZIL). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Pembrolizumab Export Value and How Much Does Speciality Medicines Private Limited Contribute?
India exported $1.7M worth of Pembrolizumab through 215 shipments from 34 suppliers to 21 countries, serving 66 buyers globally. Speciality Medicines Private Limited contributes $159.8K to this total, accounting for 8.3% of India's Pembrolizumab exports. Speciality Medicines Private Limited ships Pembrolizumab to 3 countries through 6 buyers.
What Is the Average Shipment Value for Speciality Medicines Private Limited's Pembrolizumab Exports?
Speciality Medicines Private Limited's average Pembrolizumab shipment value is $8.4K per consignment, based on 19 shipments totaling $159.8K. The largest destination is BRAZIL (89.5% of Speciality Medicines Private Limited's Pembrolizumab exports).
How Does Speciality Medicines Private Limited Compare to Other Indian Pembrolizumab Exporters?
Speciality Medicines Private Limited ranks #6 among 34 Indian Pembrolizumab exporters with a 8.3% market share. The top 3 exporters are GNH INDIA PHARMACEUTICALS LIMITED ($285.3K), GEMINI HEALTHWORLD LLP ($212.6K), 3S PHARMACEUTICALS INDIA PRIVATE LIMITED ($201.7K). Speciality Medicines Private Limited processed 19 shipments to 3 destination countries.
What Pembrolizumab Formulations Does Speciality Medicines Private Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| HARMLESS PHARMACEUTICAL MEDICINES FOR HUMAN USE PEMBROLIZUMAB 100MG/4ML INJECTION | $149.2K | 19 |
| HARMLESS PHARMACEUTICAL MEDICINES FOR HUMAN USE PEMBROLIZUMAB INJECTION 100 MG /4ML | $32.2K | 4 |
| HARMLESS PHARMACEUTICAL MEDICINES FOR HUMAN USE PEMBROLIZUMAB INJECTION 100MG/4ML | $20.0K | 2 |
| HARMLESS PHARMACEUTICAL MEDICINES FOR HUMAN USE PEMBROLIZUMAB 100MG/4ML INJECTIONSET | $19.1K | 2 |
| HARMLESS PHARMACEUTICAL MEDICINES FOR HUMAN USE:PEMBROLIZUMAB INJECTION 100MG/4ML | $18.3K | 2 |
| HARMLESS PHARMACEUTICAL MEDICINES FOR HUMAN USE PEMBROLIZUMAB 100MG/4ML INJECTIONNOS | $12.9K | 2 |
| HARMLESS PHARMACEUTICAL MEDICINES FOR HUMAN USE PEMBROLIZUMAB 100MG/4ML INJECTION AS PER INVOICE | $11.3K | 1 |
| HARMLESS PHARMACEUTICAL MEDICINES FOR HUMAN USE- PEMBROLIZUMAB 100MG/4ML INJECTION,BATCH NO: X018554SET | $9.5K | 1 |
| HARMLESS PHARMACEUTICAL MEDICINES FOR HUMAN USE PEMBROLIZUMAB 100 MG/4ML INJECTION AS PER INVOICESET | $9.2K | 1 |
| HARMLESS PHARMACEUTICAL MEDICINES FOR HUMAN USE PEMBROLIZUMAB INJECTION 100 MG 4ML | $9.1K | 1 |
Speciality Medicines Private Limited exports 14 distinct Pembrolizumab formulations including tablets, capsules, syrups, and combination drugs. The top formulation is HARMLESS PHARMACEUTICAL MEDICINES FOR HUMAN USE PEMBROLIZUMA with 19 shipments worth $149.2K.
Regulatory Requirements: Exporting Pembrolizumab to Key Markets
What Speciality Medicines Private Limited must comply with to export Pembrolizumab to its top destination countries
Brazil — ANVISA
Approval Process
Generic registration under RDC 200/2017. ANVISA GMP inspection of Indian facility mandatory before approval.
Timeline: 12–24 months
GMP & Export Requirements
ANVISA GMP certificate (CBPF) for each manufacturing site; on-site inspection by ANVISA
Certificate of Pharmaceutical Product from CDSCO; Import Authorization via SISCOMEX
Note: ANVISA maintains active Indian pharma facility inspection program. Inspection backlog can extend timelines.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does Speciality Medicines Private Limited Compare to Nearest Pembrolizumab Exporters?
Exporters ranked immediately above and below #6 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 4 | VAMA LIFECARE PRIVATE LIMITED | $181.3K | 19 | 1 | $9.5K |
| 5 | SHREE KRISHNA LIFECARE | $174.0K | 10 | 3 | $17.4K |
| 6 | SPECIALITY MEDICINES PRIVATE LIMITED ★ | $159.8K | 19 | 3 | $8.4K |
| 7 | SPECIALITY MEDICINES LIMITED | $159.1K | 20 | 2 | $8.0K |
| 8 | NU HOSPITALS PRIVATE LIMITED | $130.1K | 30 | 1 | $4.3K |
Speciality Medicines Private Limited ranks #6 among 34 Indian Pembrolizumab exporters. Average shipment value of $8.4K compared to the market average of $50.2K. The closest competitors by value are VAMA LIFECARE PRIVATE LIMITED and SHREE KRISHNA LIFECARE.
Which Indian Ports Ship Pembrolizumab Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR | 47 | 21.9% |
| AHEMDABAD AIR ACC (INAMD4) | 33 | 15.3% |
| DELHI AIR CARGO ACC (INDEL4) | 25 | 11.6% |
| DELHI AIR | 19 | 8.8% |
| AHEMDABAD AIR | 17 | 7.9% |
| SAHAR AIR CARGO ACC (INBOM4) | 15 | 7.0% |
| BANGALORE ACC (INBLR4) | 13 | 6.0% |
| BANGALORE AIR | 10 | 4.7% |
What Other Advanced Oncology Products Does Speciality Medicines Private Limited Export?
Speciality Medicines Private Limited also exports these advanced oncology products. Each links to the detailed product page.
About Speciality Medicines Private Limited
Speciality Medicines Private Limited exports 4 products worth $217.1K. Beyond Pembrolizumab, top products include Nivolumab, Osimertinib, Catheter. View the complete Speciality Medicines Private Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Pembrolizumab — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Pembrolizumab shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Speciality Medicines Private Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 39 individual customs records matching Speciality Medicines Private Limited exporting Pembrolizumab, covering 14 formulations to 3 countries via 6 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 21+ countries, 66+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Pembrolizumab Export Data from Speciality Medicines Private Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Speciality Medicines Private Limited's Pembrolizumab exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Speciality Medicines Private Limited
Full Company Profile →
4 products · $217.1K total trade · 2 categories
Pembrolizumab Stats
Company Overview
Top Products by Speciality Medicines Private Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Speciality Medicines Private Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Pembrolizumab. For current shipment-level data, contact TransData Nexus.